SPAG9 and ovarian cancer: It can be reasoned that the higher concentrations of LPA in ovarian cancer, in conjunction with the increased expression of JLP in ovarian cancers can stimulate intraperitoneal metastatic invasive migration of ovarian cancer cells and promotes aggressive tumor growth.